Monday 6th July 2020
|
10.00 - 10.40 |
Muscle & Bone Oral Communications Chairs: Dimitris Vlachopoulos (Exeter) & Sarah Allison (Surrey) |
|
10.00 |
Cholecalciferol supplementation in pregnancy is associated with greater offspring bone and lean mass at 4 years: findings from the MAVIDOS randomised controlled trial Elizabeth Curtis (Southampton)
|
|
10.10 |
Physical activity through adolescence and hip bone mineral density in young adults: prospective cohort and negative control study Ahmed Elhakeem (Bristol)
|
|
10.20 |
How does radiographic knee osteoarthritis impact musculoskeletal aging in midlife? Findings from the Hertfordshire Cohort study Nicholas Fuggle (Southampton)
|
|
10.30 |
Vertebral fractures and daily pain are associated with lower physical activity in postmenopausal women with back pain Gallin Montgomery (Manchester)
|
|
11.30 - 12.15 |
Industry Symposium – Alexion |
|
14.30 - 15.15 |
Industry Symposium – Kyowa Kirin |
|
16.00 - 17.30 |
Rare Bone Disease Workshop Kindly supported by Alexion & Kyowa Kirin Chairs: Kassim Javaid (Oxford) & Zulf Mughal (Manchester) |
|
16.00 |
Introduction and welcome
|
|
16.05 |
Case discussion: Is it metabolic bone disease? Frank Rutsch (Münster, Germany)
|
|
16.20 |
Treating Hypophosphatasia in Adult: The UK experience Katie Moss (London, UK)
|
|
16.35 |
Fibrodysplasia ossificans progressiva: current and potential therapies Judith Bubbear (Stanmore, UK)
|
|
16.50 |
How to transition well - current practice and research needs Jenny Walsh (Sheffield, UK)
|
|
17.05 |
Rare forms of OI; where are we heading Frank Rauch (Montreal, Canada)
|
17.30 - 17.45 BREAK
|
17.45 - 18.25 |
Rare Bone Disease Workshop - Oral Communications Chairs: Kassim Javaid (Oxford) & Zulf Mughal (Manchester) |
|
17.45 |
Osteoarticular morbidity before and after disease modifying therapy in a cohort of patients with alkaptonuria in the United Kingdom National Alkaptonuria Centre Lakshminarayan R Ranganath (Liverpool)
|
|
17.55 |
Tendon properties in a new mouse model of moderate-severe dominant Osteogenesis Imperfecta Larissa Sinkam (Montreal, Canada)
|
|
18.05 |
Significantly impaired grip force in children with Neurofibromatosis Type 1 Amish Chinoy (Manchester)
|
|
18.15 |
A mouse model of juvenile onset X-linked osteoporosis Bernard Freudenthal (London)
|
Tuesday 7th July 2020
|
10.00 - 10.40 |
Paediatric Bone Disease Oral Communications Chair: Elizabeth Curtis (Southampton) |
|
10.00 |
Lumbar spine quantitative computed tomography (QCT) is a better predictor of vertebral fracture in boys with Duchenne muscular dystrophy (DMD) than either DXA or peripheral QCT Nicola Crabtree (Birmingham)
|
|
10.10 |
Children living with HIV in Zimbabwe have impaired trabecular and cortical bone architecture, despite treatment with anti-retroviral therapy Cynthia Kahari (Harare, Zimbabwe)
|
|
10.20 |
The Impact of HIV on Skeletal Maturation in Zimbabwean Children and Adolescents Farirayi Nyakoko (Harare, Zimbabwe)
|
|
10.30 |
Placental volume at 11 weeks is associated with offspring bone mass at birth and in later childhood: findings from the Southampton women’s survey Stephen Woolford (Southampton)
|
|
14.00 - 14.40 |
Cancer & Bone Oral Communications Chair: Leni Green (Sheffield) |
|
14.00 |
Overall fracture incidence in multiple myeloma patients relative to general population controls: a parallel cohort study of the UK CPRD Samuel Hawley (Oxford)
|
|
14.10 |
Interleukin-1B regulates metastatic breast cancer to bone; affects through tumour-associated innate immune response Penelope Ottewell (Sheffield)
|
|
14.20 |
Inhibition of Autophagy Prevents Chemoresistance in High Grade Osteosarcoma Janice Salena Pereira (London)
|
|
14.30 |
Assessing the Impact of Ovarian Suppression Therapy (OST) on Bone Health in Premenopausal Women Treated for Breast Cancer. David Riley (Manchester)
|
|
16.00 |
Industry Symposium – UCB |
Wednesday 8th July 2020
|
10.00 - 10.50 |
Bone Health Oral Communications Chairs: Claire Clarkin (Southampton) & Elaine Dennison (Southampton) |
|
10.00 |
Is fracture risk screening using Frax effective for secondary fracture prevention? A post-hoc analysis of the SCOOP trial Camille Parsons (Southampton)
|
|
10.10 |
Associations between inflammation, adiposity and bone mineral density: do they differ between ethnicities in a UK-based tri-ethnic cohort? Ruth Durdin (Southampton)
|
|
10.20 |
Near infrared spectroscopy for the investigation of vascular haemodynamics of human bone in vivo. Robert Meertens (Exeter)
|
|
10.30 |
A stable form of sulforaphane, generates bone mass gains, is anti-osteoclastogenic in vitro and protects against pain onset in a spontaneous model of mouse OA Polymnia Louka (London)
|
|
10.40 |
Characterisation of subchondral cysts in a murine model of spontaneous osteoarthritis Rebecca Norman (London)
|
|
11.15 - 12.15 |
BRS Annual General Meeting (AGM) - members only |
|
14.00 - 14.40 |
Basic Science Oral Communications Chair: Isabel Orriss (London) |
|
14.00 |
Decoding the biochemistry of matrix vesicles during biomineralisation: Is ENPP6 upstream of PHOSPHO1? Scott Dillon (Edinburgh)
|
|
14.10 |
Mitoguardin-2 deficiency results in severe osteoporosis David Komla Ebri (London)
|
|
14.20 |
Opposing effects of miR-138 and miR-181a/b-1 on bone formation and repair. Audrey McAlinden (St Louis, USA)
|
|
14.30 |
Slc38a10 is a novel regulator of osteoblastic bone formation Andrea Pollard (London)
|
